meningococcal disease

Pfizer’s new shot approval adds to a growing vaccine prowess
Pfizer’s new shot approval adds to a growing vaccine prowess
Pharma Voice
Pfizer
vaccines
meningococcal disease
COVID-19
Penbraya
Flag link:
Pfizer beats out GSK with FDA nod for first 5-in-1 meningitis shot
Pfizer beats out GSK with FDA nod for first 5-in-1 meningitis shot
Fierce Pharma
Pfizer
GSK
vaccines
FDA
Penbraya
meningococcal disease
Flag link:
Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Fierce Pharma
vaccines
GSK
Pfizer
meningococcal disease
Menveo
Bexsero
Flag link:
FDA accepts BLA for Pfizer’s meningococcal vaccine candidate
FDA accepts BLA for Pfizer’s meningococcal vaccine candidate
Pharmaceutical Business Review
Pfizer
FDA
vaccines
meningococcal disease
MenABCWY
Flag link:
FDA approves single-vial version of GSK's Menveo vaccine, ending need for reconstitution
FDA approves single-vial version of GSK's Menveo vaccine, ending need for reconstitution
Fierce Pharma
GSK
FDA
vaccines
Menveo
meningococcal disease
Flag link:
Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine
Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine
Endpoints
Pfizer
vaccine
meningococcal disease
clinical trials
MenABCWY
Flag link:
FDA Approves Sanofi’s Meningococcal Meningitis Vaccine
FDA Approves Sanofi’s Meningococcal Meningitis Vaccine
BioSpace
FDA
Sanofi
vaccines
MenQuadfi
meningococcal conjugate vaccine
meningococcal disease
Flag link:
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Fierce Pharma
Sanofi
meningococcal disease
Novartis
vaccines
Menveo
Menactra
Flag link:
GSK to overtake Sanofi atop meningococcal vaccine market, report predicts
GSK to overtake Sanofi atop meningococcal vaccine market, report predicts
Fierce Pharma
GSK
Sanofi
vaccines
meningococcal disease
Menactra
Bexsero
MenABCWY
Flag link:
Sanofi's Menactra Gets FDA Approval As Booster Vaccine
Sanofi's Menactra Gets FDA Approval As Booster Vaccine
Bidness Etc.
Sanofi
Menactra
FDA
vaccines
meningococcal disease
Flag link:
Pfizer announces 'positive' bivalent rLP2086 Phase 2 study results
Pfizer announces 'positive' bivalent rLP2086 Phase 2 study results
The Fly on the Wall
Pfizer
bivalent rLP2086
vaccines
meningococcal disease
Flag link:
Sanofi's Menactra Data Published
Sanofi's Menactra Data Published
Yahoo/Zacks
Sanofi
Menactra
vaccines
meningococcal disease
Flag link:
Third Time Lucky for Glaxo
Third Time Lucky for Glaxo
Yahoo/Zacks
MenHibrix
vaccinces
meningococcal disease
Flag link:
Who Would Have Ever Thought A Vaccine To Protect Babies' Brains Could Be A Tough Sell?
Who Would Have Ever Thought A Vaccine To Protect Babies' Brains Could Be A Tough Sell?
Forbes
vaccines
Novartis
Menveo
Bexsero
meningococcal disease
Flag link:
Novartis Says FDA Approves Menveo in Kids, Not Infants
Novartis Says FDA Approves Menveo in Kids, Not Infants
Bloomberg
FDA
Novartis
vaccines
Menveo
meningococcal disease
Flag link:
Novartis trial of meningococcal vaccine meets goal
Novartis trial of meningococcal vaccine meets goal
Marketwatch
Novartis
vaccines
Menveo
meningococcal disease
Flag link: